Skip to main content
logo
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.3931
+0.0025 (0.64%)
At close: Jul 24, 2026, 4:00 PM EDT
0.4183
+0.0252 (6.41%)
After-hours: Jul 24, 2026, 7:46 PM EDT

Vivos Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
19.5717.4415.0313.816.0216.89
Revenue Growth
33.77%16.05%8.91%-13.87%-5.10%29.23%
Gross Profit
12.0910.549.028.2710.0212.6
Operating Income
-22.6-19.89-11.17-17.3-25.03-20.38
Net Income
-25.12-21.17-11.14-13.58-23.85-20.29
Earnings Per Share
-2.14-2.07-2.22-11.14-25.90-23.88
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.112.036.261.643.5224.03
Total Debt
12.2713.51.5122.411.27
Net Cash (Debt)
-10.16-11.474.75-0.351.1122.77
Net Cash Growth
-----95.14%34.58%
Net Cash Per Share
-0.86-1.120.46-0.000.000.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.48-15.26-12.69-11.95-19.59-15.74
Capital Expenditures
-2.24-2.34-0.57-0.8-0.92-2.4
Free Cash Flow
-19.71-17.6-13.26-12.75-20.51-18.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.80%60.44%60.00%59.93%62.52%74.65%
Operating Margin
-115.47%-114.05%-74.32%-125.32%-156.21%-120.71%
Pretax Margin
-128.36%-121.71%-74.09%-98.42%-148.81%-120.15%
Profit Margin
-128.36%-121.71%-74.09%-98.42%-148.81%-120.15%
FCF Margin
-100.75%-100.92%-88.21%-92.38%-128.00%-107.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.281.081.681.650.583.07